Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Multiple myeloma.

× No keyword cloud information.

864 in total

1. Improved survival in Medicare patients with multiple myeloma: findings from a large nationwide and population-based cohort.

Authors: Ying Chen; David R Lairson; Wenyaw Chan; Xianglin L Du
Journal: Med Oncol Date: 2017-08-03 Impact factor: 3.064

2. Necrobiotic xanthogranuloma.

Authors: Yvonne Efebera
Journal: Clin Adv Hematol Oncol Date: 2011-09

3. EphA3 targeting reduces in vitro adhesion and invasion and in vivo growth and angiogenesis of multiple myeloma cells.

Authors: Francesco La Rocca; Irma Airoldi; Emma Di Carlo; Pina Marotta; Geppino Falco; Vittorio Simeon; Ilaria Laurenzana; Stefania Trino; Luciana De Luca; Katia Todoerti; Oreste Villani; Martin Lackmann; Fiorella D'Auria; Francesco Frassoni; Antonino Neri; Luigi Del Vecchio; Pellegrino Musto; Daniela Cilloni; Antonella Caivano
Journal: Cell Oncol (Dordr) Date: 2017-07-18 Impact factor: 6.730

4. Histone deacetylase inhibitor NaBut suppresses cell proliferation and induces apoptosis by targeting p21 in multiple myeloma.

Authors: Ruosi Yao; Danyang Han; Xiaoyang Sun; Chunling Fu; Qingyun Wu; Yao Yao; Hujun Li; Zhenyu Li; Kailin Xu
Journal: Am J Transl Res Date: 2017-11-15 Impact factor: 4.060

5. Optimizing dendritic cell vaccine for immunotherapy in multiple myeloma: tumour lysates are more potent tumour antigens than idiotype protein to promote anti-tumour immunity.

Authors: S Hong; H Li; J Qian; J Yang; Y Lu; Q Yi
Journal: Clin Exp Immunol Date: 2012-11 Impact factor: 4.330

Review 6. Myeloma and Bone Disease.

Authors: Cristina Panaroni; Andrew J Yee; Noopur S Raje
Journal: Curr Osteoporos Rep Date: 2017-10 Impact factor: 5.096

7. Targeting PYK2 mediates microenvironment-specific cell death in multiple myeloma.

Authors: M B Meads; B Fang; L Mathews; J Gemmer; L Nong; I Rosado-Lopez; T Nguyen; J E Ring; W Matsui; A R MacLeod; J A Pachter; L A Hazlehurst; J M Koomen; K H Shain
Journal: Oncogene Date: 2015-09-21 Impact factor: 9.867

8. Decreased affinity of recombinant human tumor necrosis factor-related apoptosis-inducing ligand (rhTRAIL) D269H/E195R to osteoprotegerin (OPG) overcomes TRAIL resistance mediated by the bone microenvironment.

Authors: Matthieu C J Bosman; Carlos R Reis; Jan J Schuringa; Edo Vellenga; Wim J Quax
Journal: J Biol Chem Date: 2013-11-26 Impact factor: 5.157

9. Downregulation of miRNA-15a and miRNA-16 promote tumor proliferation in multiple myeloma by increasing CABIN1 expression.

Authors: Lei Zhang; Lin Zhou; Meng Shi; Yong Kuang; Lei Fang
Journal: Oncol Lett Date: 2017-11-15 Impact factor: 2.967

Review 10. Functional and molecular MRI of the bone marrow in multiple myeloma.

Authors: Vassilis Koutoulidis; Nickolas Papanikolaou; Lia A Moulopoulos
Journal: Br J Radiol Date: 2018-02-13 Impact factor: 3.039